Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 5/2018

01-05-2018 | Head and Neck

Sentinel lymph node biopsy in cutaneous head and neck melanoma

Authors: D. Evrard, E. Routier, C. Mateus, G. Tomasic, J. Lombroso, F. Kolb, C. Robert, A. Moya-Plana

Published in: European Archives of Oto-Rhino-Laryngology | Issue 5/2018

Login to get access

Abstract

Purpose

Sentinel lymph node biopsy (SLNB) is now a standard of care for cutaneous melanoma, but it is still controversial for cutaneous head and neck melanoma (CHNM). This study aims to confirm the feasibility, accuracy and low morbidity of SLNB in CHNM and evaluate its prognostic value.

Methods

A monocentric and retrospective study on patients with CHNM treated in our tertiary care center (Gustave Roussy) between January 2008 and December 2012 was performed. The feasibility, morbidity and prognostic value of this technique were analysed.

Results

One hundred and twenty-four consecutive patients were included. SLNB was realized in 97.6% of the cases. No significant post-operative morbidity was observed. Nineteen percents of patients had a positive SN while only 14.3% of complete lymph node dissections (CLND) had additional nodal metastasis. The risk of recurrence after positive SN was significantly higher (69.2 vs 30.8%, p = 0.043). The false omission rate was low with 7.1%. Overall survival and disease-free survival were better in the negative SN group (82 vs 49%, p < 0.001 and 69.3 vs 41.8%, p = 0.0131). The risk of recurrence was significantly higher in the positive SN group (p = 0.043) and when primary tumour was ulcerated (p = 0.031). Only the mitotic rate of the primary tumour was associated with SN positivity (p = 0.049).

Conclusion

As in other sites, SLNB status is a strong prognostic factor with comparable false omission rate and no superior morbidity.
Literature
3.
go back to reference Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609. https://doi.org/10.1056/NEJMoa1310460 CrossRefPubMedPubMedCentral Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599–609. https://​doi.​org/​10.​1056/​NEJMoa1310460 CrossRefPubMedPubMedCentral
5.
9.
13.
go back to reference Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, Vermey A, Plukker JT, Hoefnagel CA, Piers DA, Kroon BB (2000) Sentinel node biopsy for melanoma in the head and neck region. Head Neck 22:27–33. https://doi.org/10.1002/(SICI)1097-0347(200001)22:1<27::AID-HED5>3.0.CO;2-ZCrossRefPubMed Jansen L, Koops HS, Nieweg OE, Doting MH, Kapteijn BA, Balm AJ, Vermey A, Plukker JT, Hoefnagel CA, Piers DA, Kroon BB (2000) Sentinel node biopsy for melanoma in the head and neck region. Head Neck 22:27–33. https://​doi.​org/​10.​1002/​(SICI)1097-0347(200001)22:1<27::AID-HED5>3.0.CO;2-ZCrossRefPubMed
20.
go back to reference Kaveh AH, Seminara NM, Barnes MA, Berger AJ, Chen FW, Yao M, Johnson D, Parsa S, Quon A, Swetter SM, Sunwoo JB (2016) Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men. Head Neck 38(Supplement 1):E754–E760. https://doi.org/10.1002/hed.24094 CrossRefPubMed Kaveh AH, Seminara NM, Barnes MA, Berger AJ, Chen FW, Yao M, Johnson D, Parsa S, Quon A, Swetter SM, Sunwoo JB (2016) Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men. Head Neck 38(Supplement 1):E754–E760. https://​doi.​org/​10.​1002/​hed.​24094 CrossRefPubMed
23.
go back to reference Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S (2014) Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 40:305–310. https://doi.org/10.1016/j.ejso.2013.11.017 Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S (2014) Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 40:305–310. https://​doi.​org/​10.​1016/​j.​ejso.​2013.​11.​017
25.
go back to reference Leong SPL, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ, Sentinel Lymph Node Working Group (2006) Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 132:370–373. https://doi.org/10.1001/archotol.132.4.370 CrossRefPubMed Leong SPL, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ, Sentinel Lymph Node Working Group (2006) Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 132:370–373. https://​doi.​org/​10.​1001/​archotol.​132.​4.​370 CrossRefPubMed
26.
go back to reference Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, de Pril V, de Schaetzen G, Suciu S, Testori A (2016) Prolonged survival in Stage III melanoma with Ipilimumab adjuvant therapy. N Engl J Med 375:1845–1855. https://doi.org/10.1056/NEJMoa1611299 CrossRefPubMedPubMedCentral Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, de Pril V, de Schaetzen G, Suciu S, Testori A (2016) Prolonged survival in Stage III melanoma with Ipilimumab adjuvant therapy. N Engl J Med 375:1845–1855. https://​doi.​org/​10.​1056/​NEJMoa1611299 CrossRefPubMedPubMedCentral
Metadata
Title
Sentinel lymph node biopsy in cutaneous head and neck melanoma
Authors
D. Evrard
E. Routier
C. Mateus
G. Tomasic
J. Lombroso
F. Kolb
C. Robert
A. Moya-Plana
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 5/2018
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-4934-3

Other articles of this Issue 5/2018

European Archives of Oto-Rhino-Laryngology 5/2018 Go to the issue